Olfactory Neuroblastoma

• CLINICAL_TRIALS trial_result · 2026-04-08
  Clinical Trial Update: Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors [Phase 2]

  Phase 2 clinical trial evaluating the IDH2 inhibitor enasidenib (Idhifa) in IDH2-mutated malignant sinonasal and skull base tumors is curren…

• CLINICAL_TRIALS trial_result · 2025-08-08
  Clinical Trial Update: Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON). [Phase 2]

  A Phase 2 BARON trial evaluating bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma has completed, and the results have been po…